Does evolocumab reduce cardiovascular events in adults with diabetes?

1 min readUpdated June 7, 2026

What the Evidence Shows

We analyzed three assertions about evolocumab in adults with diabetes, and all support the idea that adding this drug to statin therapy may lower the chance of heart attack, stroke, or needing a procedure to restore blood flow over five years. None of the evidence we reviewed contradicts this. ...

Evidence from Studies

Supporting (0)
No supporting evidence found
Contradicting (0)
No contradicting evidence found
Primary Studies (1)

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes

DOI: 10.1001/jama.2026.3277

Update History

Published
June 7, 2026·Last updated June 7, 2026
  • Invalid DateNew topic created from assertion
  • Invalid Datenew evidence added
  • Invalid DateNew topic created from assertion

Sign up to see full analysis

Does evolocumab reduce cardiovascular events in adults with diabetes? | Evidence-Based Answer | Fit Body Science